Surgalign Holdings Q2 EPS $(0.05) Beats $(0.12) Estimate, Sales $24.80M Inline

Surgalign Holdings (NASDAQ:SRGA) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.12) by 58.33 percent. This is a 84.38 percent increase over losses of $(0.32) per share

Surgalign Holdings (NASDAQ:SRGA) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.12) by 58.33 percent. This is a 84.38 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $24.80 million which met the analyst consensus estimate. This is a 54.26 percent decrease over sales of $54.23 million the same period last year.

Total
0
Shares
Related Posts
Read More

Thorne HealthTech Earnings Preview

Thorne HealthTech (NASDAQ:THRN) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that Thorne HealthTech will report an earnings per share (EPS) of $0.14.

THRN